
Mounjaro KwikPen: Eli Lilly and Company's Type 2 Diabetes and Obesity Drug Gets Approval in India, To Compete With Novo'...
Mumbai, June 27: In what can be seen as good news for those suffering from diabetes and obesity in India, the Central Drugs Standard Control Organisation (CDSCO) has granted marketing authorisation for Eli Lilly and Company's Mounjaro tirzepatide drug. …